Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.400
-0.140 (-9.09%)
At close: Nov 20, 2024, 4:00 PM
1.470
+0.070 (5.00%)
After-hours: Nov 20, 2024, 4:24 PM EST
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $7.81 million as of November 21, 2024. Its market cap has decreased by -76.05% in one year.
Market Cap
7.81M
Enterprise Value
3.23M
1-Year Change
-76.05%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $7.81M, a decrease of -95.93%. That is a compound annual growth rate of -57.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 7.81M | -69.95% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Conduit Pharmaceuticals | 9.45M |
| Ensysce Biosciences | 9.43M |
| BioRestorative Therapies | 9.38M |
| Mobile-health Network Solutions | 9.31M |
| Evogene | 9.30M |
| Jaguar Health | 9.05M |
| Precipio | 9.00M |
| RedHill Biopharma | 8.95M |